Skip to main content
Clinical Trials/NL-OMON42623
NL-OMON42623
Not Yet Recruiting
N/A

ong-term neuropsychological outcome in pediatric anti-NMDAR encephalitis - Outcome in pediatric NMDARE

eurologie0 sites50 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
hersenontsteking
Sponsor
eurologie
Enrollment
50
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
eurologie

Eligibility Criteria

Inclusion Criteria

  • \- Cross\-sectional part: patients who have had anti\-NMDA receptor encephalitis before January 2015, who were age 18 or younger at disease onset and currently age 4 or older.
  • \- Prospective parts: patients who have had anti\-NMDA receptor encephalitis after January 2015, who were age 3\.5 to 18 at disease onset
  • \- Patient was diagnosed in Dutch tertiary pediatric hospitals, or antibody testing had been performed in our center.
  • \- Patient speaks Dutch or English.

Exclusion Criteria

  • \- Age over 18 years at disease onset, or current age younger than 4
  • \- Patient or legal representative is withholding informed consent
  • \- Patient or legal representative objects after initial informed consent (see paragraph 8\.4\)

Outcomes

Primary Outcomes

Not specified

Similar Trials